Dysferlin and animal models for dysferlinopathy.

J Toxicol Pathol · 2012 · PMC3392904 · PMID 22907980

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Read-through by small-molecule drugs Phase IIb trials of ataluren (PTC124), which causes read-through for the nonsense mutation DMD/BMD, has been suspended or terminated because the primary endpoint did not reach statistical significance within the 48-week duration of the study (http://clinicaltrials.gov/ct2/results?term=PTC124).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.